The abstract is read at the publisher; the summary is JClub's.
Transapical beating-heart septal myectomy in 97 symptomatic nonobstructive hypertrophic cardiomyopathy patients achieved 87.6% procedural success at 6–12 months, with major symptom and cavity gains.
- Why it matters: Symptomatic nonobstructive hypertrophic cardiomyopathy has heterogeneous mechanisms and limited effective options for drug-refractory patients, creating a need for safer, targeted therapies.
- What they did: From January 2023 to January 2025 at Tongji Hospital, patients underwent left minithoracotomy with real-time transesophageal echocardiography–guided septal resection; success required NYHA, Kansas City score, stroke volume, and diastolic function improvements.
- The result: At 6–12 months, NYHA class I rose to 93.8%, Kansas City score increased from 64 to 87 (P<0.001), stroke volume from 53.5 to 70.8 mL (P<0.001), and normal/grade I diastolic function from 65.6% to 97.9%; peak oxygen uptake rose by 1.1±2.9 mL/kg/min (P=0.008) with 1 death after ventricular septal perforation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.